Name: Abiomed Inc. (NASDAQ:ABMD) | Balance Sheet: Assets
Creator: Stock Analysis on Net

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Abiomed Inc., consolidated balance sheet: assets

US$ in thousands

	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Cash and cash equivalents	132,818)	232,710)	192,341)	121,021)	42,975)	39,040)
Short-term marketable securities	625,789)	350,985)	250,775)	370,677)	319,274)	190,908)
Accounts receivable, net	90,608)	97,179)	84,650)	90,809)	70,010)	54,055)
Inventories, net	93,981)	81,059)	90,088)	80,942)	50,204)	34,931)
Prepaid expenses and other current assets	33,277)	26,032)	18,009)	13,748)	11,808)	8,024)
Current assets	976,473)	787,965)	635,863)	677,197)	494,271)	326,958)
Long-term marketable securities	220,089)	264,085)	207,795)	21,718)	37,502)	47,143)
Property and equipment, net	202,490)	197,129)	164,931)	145,005)	117,167)	87,777)
Goodwill	76,786)	78,568)	31,969)	32,601)	35,808)	31,045)
Other intangibles, net	39,518)	42,150)	14,913)	15,208)	16,705)	14,482)
Deferred tax assets	10,552)	11,380)	43,336)	77,502)	70,746)	34,723)
Investment in Shockwave Medical	61,535)	38,655)	55,704)	56,195)	—)	—)
Other investments	70,314)	62,995)	38,741)	24,584)	—)	—)
Operating lease right-of-use assets	9,518)	6,109)	11,760)	—)	—)	—)
Cross-currency swap	—)	—)	3,786)	—)	—)	—)
Other intangible assets and other assets	6,118)	5,323)	7,664)	4,336)	14,176)	8,286)
Other assets	147,485)	113,082)	117,655)	85,115)	14,176)	8,286)
Long-term assets	696,920)	706,394)	580,599)	377,149)	292,104)	223,456)
Total assets	1,673,393)	1,494,359)	1,216,462)	1,054,346)	786,375)	550,414)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Total assets exhibited a strong growth trajectory over the analyzed period, increasing from US$ 550.4 million in 2017 to US$ 1.67 billion by March 31, 2022. This expansion is characterized by significant growth in both current and long-term asset categories, reflecting a substantial increase in the company's overall scale and resource base.

Liquidity and Cash Management: Current assets grew from US$ 326.9 million in 2017 to US$ 976.5 million in 2022. A strategic shift in liquidity management is observed; while cash and cash equivalents peaked in 2021 at US$ 232.7 million before declining to US$ 132.8 million in 2022, short-term marketable securities grew aggressively from US$ 190.9 million to US$ 625.8 million over the same period. This pattern suggests a transition toward higher-yield liquid instruments to optimize the return on idle cash.
Operational Asset Trends: Inventories demonstrated a consistent upward trend, increasing from US$ 34.9 million in 2017 to US$ 94.0 million in 2022, which may indicate scaled-up operations or a strategic increase in safety stock. Net property and equipment followed a similar growth path, rising from US$ 87.8 million to US$ 202.5 million, signaling steady investment in physical infrastructure. Accounts receivable remained relatively stable in the latter half of the period, fluctuating between US$ 84.7 million and US$ 97.2 million from 2020 to 2022.
Strategic Investments and Intangibles: A notable surge in intangible assets occurred in 2021, with goodwill increasing to US$ 78.6 million and other intangibles rising to US$ 42.2 million, a pattern typically associated with acquisition activity. Furthermore, the company initiated strategic investments in 2019, including a position in Shockwave Medical and other investment vehicles, which collectively grew to US$ 131.8 million by March 31, 2022.
Long-Term Asset Volatility and Tax Assets: Long-term marketable securities showed significant volatility, increasing sharply from US$ 21.7 million in 2019 to a peak of US$ 264.1 million in 2021. Conversely, deferred tax assets experienced a substantial decline, falling from a peak of US$ 77.5 million in 2019 to US$ 10.6 million in 2022, suggesting the utilization of tax losses or changes in tax valuations.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?